Program Results

Recurring Programs

Rapid Response
Seed funding (up to $150,000 for up to 18 months) for high-risk, high-reward, totally novel ideas.
2013 | 2012

Transformational Research
Larger, longer grants (up to $1.5m for up to 3 years) for transformational work including international collaborations.
2014 | 2013

One-Time Programs

Early Clinical Trials 2014
Larger, longer grants (up to $1.5m for up to 4 years) for projects focusing on Phase I or IIa clinical trials. For applicants invited to the LOI stage, the Institute will provide access to clinical trial design experts to help with their proposals.

Targeted Diseases 2014: FTD/PSP
The goal of the Targeted Diseases program is to provide targeted support for high impact, translational research in frontotemporal dementia (FTD) and progressive supranuclear palsy (PSP).

Collaborative Programs

The W. Garfield Weston Foundation – Alzheimer’s Drug Discovery Foundation – Canada (ADDF-Canada) Grant
Three-year grant to support clinical trials for Alzheimer’s therapeutics through the ADDF-Canada’s Program to Accelerate Clinical Trials (PACT).
Download Press Release

The W. Garfield Weston Foundation – Brain Canada Foundation Multi-Investigator Research Initiative (MIRI)
Three-year team based grants for transformative grants for research aimed at improving our understanding of human nervous system function and dysfunction and its impact on health.
Download Press Release

The W. Garfield Weston Foundation – Michael J. Fox Foundation Grants
Funding for 9 teams across Canada working on promising treatments for Parkinson’s disease.